Mark J. Foley
Overview
Mark J. Foley received an average of $11M in total compensation, including $500K in salary, at Revance Therapeutics from 2019 to 2021.
Source: SEC filings on March 24, 2022, March 24, 2021, and March 26, 2020.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Dustin Sjuts
Revance Therapeutics
President
Aubrey Rankin
Revance Therapeutics
Former President, Innovation & Technology
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
L Browne
Revance Therapeutics
Chief Executive Officer
Caryn McDowell
Revance Therapeutics
General Counsel
Todd Zavodnick
Revance Therapeutics